Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |